Hodgkin's and Non Hodgkin's Lymphoma Treatment

Written by Hexahealth Care Team, last updated on 5 June 2023
Hodgkin's and Non Hodgkin's Lymphoma Treatment

When it comes to lymphomas, Hodgkin lymphoma and non-Hodgkin lymphoma are two distinct yet interconnected types of cancer. These blood cancers originate in the lymphatic system, affecting the body’s immune response and presenting unique challenges to medical professionals. The advancements in research for non-Hodgkin and Hodgkin lymphoma treatment have brought hope and progress to patients worldwide.

With an ever-evolving landscape of treatment options and advancements in medical technology, Hodgkin’s and non-Hodgkin’s lymphoma treatment continues to push the boundaries of knowledge, offering tailored approaches to maximise patient outcomes and pave the way for a brighter future. 

The following blog discusses the various non-Hodgkin’s and Hodgkin’s lymphoma treatment options available at different stages of cancer. Continue reading to find out.

Understanding Hodgkin and Non-Hodgkin Lymphoma

Hodgkin and non-Hodgkin lymphoma are two types of cancers originating in the lymphatic system, a vital part of the body’s immune system. Lymphomas are characterised by the abnormal growth of lymphocytes, a type of white blood cell.

Hodgkin’s Lymphoma (HL)

  1. Hodgkin lymphoma, also known as Hodgkin’s disease, is a relatively rare form of lymphoma. 
  2. It is distinguished by the presence of Reed-Sternberg cells, large abnormal cells. 
  3. These are found in the lymph nodes and other lymphatic tissues. 
  4. Hodgkin lymphoma typically spreads from one group of lymph nodes to another and may involve other organs.

Non-Hodgkin’s Lymphoma (NHL)

  1. Non-Hodgkin lymphoma is a broader category that includes various types of lymphomas without Reed-Sternberg cells. 
  2. There are multiple subtypes of non-Hodgkin lymphoma, each with its distinct characteristics, prognosis, and treatment options. 
  3. Non-Hodgkin lymphoma can originate from different types of lymphocytes and affect various lymphatic tissues, including lymph nodes, bone marrow, and other organs.
get the app
get the app

Treating Hodgkin’s and Non-Hodgkin’s Lymphoma

When you are diagnosed with Hodgkin’s or non-Hodgkin’s lymphoma, the next step is to find the cancer stage. The cancer stage helps determine the amount, location, and spread of cancer in your body. Based on this information, the doctor decides the best treatment plan for the disease. 

Hodgkin and Non-Hodgkin Lymphoma Stages

The staging system used to classify Hodgkin and non-Hodgkin lymphoma is the Lugano classification, based on the old Ann Arbor system. The classification has four stages: I, II, III, and IV. 

  1. Stage I: Lymphoma is in stage I in either of the following situations:
    1. Cancer is present in only one lymph node area or lymphoid organ, like the thymus or tonsils (I). 
    2. Cancer develops in only one part of one organ outside the lymph system (IE). 
  2. Stage II: Lymphoma is in stage II in either of the following situations:
    1. Cancer is present in two or greater lymph node regions on the same side (above or below) of the diaphragm (II). 
    2. Cancer extends locally from the lymph nodes to a nearby organ (IIE). 
  3. Stage III: Lymphoma is in stage III in either of the following situations:
    1. Cancer is found in the lymph node areas on both sides of the diaphragm (III). 
    2. Cancer is present in the lymph nodes above the diaphragm and the spleen.
  4. Stage IV: Cancer has spread into at least one organ outside the lymph system, including the liver, bone marrow, or lungs.

Hodgkin Lymphoma Treatment

Several Hodgkin’s lymphoma treatment options are available, such as chemotherapy, radiation therapy, immunotherapy, targeted therapy, and stem cell transplant. However, the treatment choice varies depending on multiple factors, such as:

  1. The type of Hodgkin’s lymphoma (nodular lymphocyte-predominant and classical Hodgkin lymphoma treatment)
  2. The stage of Hodgkin’s lymphoma 
  3. Your age
  4. Your overall health
  5. Personal preferences

Stages IA and IIA, Favourable

This stage of Hodgkin’s lymphoma includes cancer in only one side of the diaphragm (either above or below) and does not constitute any unfavourable factors. The following factors characterise the stage:

  1. It is not bulky (large). 
  2. Cancer is in less than three lymph node areas.
  3. It does not cause B symptoms (fever, night sweats, and weight loss). 
  4. The Erythrocyte Sedimentation Rate or ESR (a blood test that shows inflammation in the body) is not elevated. 

The treatment modalities for Stages IA and IIA are as follows:  

  1. Chemotherapy: Usually, treatment in this early stage of the disease is chemotherapy which includes two to four cycles of an ABVD regimen (doxorubicin, bleomycin, vinblastine, dacarbazine), followed by radiation to the initial site of cancer. Selected patients may receive chemotherapy alone in three to six cycles. 
  2. Radiation Therapy: If you cannot have chemotherapy alone because of health issues, you may receive radiation therapy alone. The treatment uses high-energy beams to kill cancer cells.   
  3. Stem Cell Transplant: If you do not respond to chemotherapy and radiation, the treatment may be followed by a stem cell transplant. In this procedure, you receive healthy stem cells to replace destroyed ones. 
  4. Immunotherapy: Another option for stage 1 Hodgkin’s lymphoma treatment is immunotherapy drugs like nivolumab, brentuximab vedotin, and pembrolizumab. Immunotherapy helps boosts the immune system to fight the cancer. 

Stages I and II, Unfavourable

While the cancer is limited to only one side of the diaphragm, this stage is characterised by one or more of the following mentioned risk factors:

  1. It is bulky (the tumour is large). 
  2. Cancer is in three or more different areas of the lymph nodes. 
  3. Cancer is present outside the lymph nodes (extranodal involvement).
  4. It is causing B symptoms.
  5. The ESR is high. 

The treatment modalities for Stages I and II are as follows:

  1. Chemotherapy and Radiation: Hodgkin lymphoma treatment in this stage starts with chemotherapy drugs (the ABVD regimen for 4-6 cycles or Stanford V for 3 cycles). Chemotherapy may be followed by radiation therapy at the sites of the tumour. 
  2. Stem Cell Transplant: If you do not respond to chemotherapy and radiation, the doctor may recommend a stem cell transplant to replace the destroyed stem cells with healthy ones. 
  3. Immunotherapy: Like the favourable stage I and II of Hodgkin lymphoma, immunotherapy with drugs like nivolumab or brentuximab vedotin may be an option.

Stages III and IV

In this stage of Hodgkin lymphoma, doctors generally recommend the following treatments:

  1. Chemotherapy: While chemotherapy is also used for earlier stages, this stage includes more intense chemo regimes than earlier stages. 
    1. The ABVD regimen is used for at least six cycles. 
    2. Usually, doctors prefer more intense treatments like the Stanford V regimen for three cycles or the BEACOPP (bleomycin sulfate, etoposide phosphate, doxorubicin hydrochloride, cyclophosphamide, vincristine sulfate, procarbazine hydrochloride, and prednisone) regimen. 
    3. Sometimes, the doctor may recommend the drug brentuximab vedotin with chemotherapy. 
  2. Radiation Therapy: You may receive radiation therapy after chemotherapy, especially when there are large tumour areas. 
  3. Stem Cell Transplant: If you do not respond to other treatments, a stem cell transplant may need to be performed.
  4. Immunotherapy: Like other stages, immunotherapy with drugs like nivolumab, brentuximab vedotin, and pembrolizumab may be another option. 

A relatively newer treatment for all stages and types of Hodgkin’s lymphoma includes targeted therapy. This classic Hodgkin lymphoma treatment option uses medications to attack cancer cells. It delivers a drug to the inside of the Reed-Sternberg cells (large, atypical white blood cells found in people with Hodgkin’s lymphoma) to destroy these cells.

Non-Hodgkin Lymphoma Treatment

Several treatment options for non-Hodgkin’s lymphoma are available, including chemotherapy, radiation therapy, stem cell transplant, targeted therapy, and immunotherapy. The best treatment for NHL depends on factors such as:

  1. The stage of the disease
  2. The type of NHL
  3. Specific proteins in the cancer cells
  4. Gene changes in the cancer cells
  5. Symptoms you experience
  6. Overall health
  7. Treatment preferences

Stage I and Stage II

For early-stage Non-Hodgkin lymphoma, treatment options may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, or a combination. Treatment choice depends on the subtype and characteristics of the lymphoma and individual patient factors.

You may not need treatment immediately if you have an indolent (slow-growing) subtype of non-Hodgkin lymphoma. The doctor may monitor the lymphoma for several months with regular checkups and tests. They may recommend treatment if the cancer starts to grow. 

Stage II (bulky disease), Stage III, and Stage IV 

Advanced-stage NHL typically involves chemotherapy combined with immunotherapy, targeted therapy, or radiation therapy. 

  1. Intrathecal Chemotherapy: If there is a risk of lymphoma spreading to the fluid around your brain and spinal cord, you may need intrathecal chemotherapy. During this treatment, the healthcare team inserts a thin needle between the bones of the lower back to inject chemotherapy drugs directly into the spinal fluid. 
  2. Stem Cell Transplant: The procedure may be considered for certain cases of aggressive NHL or where cancer recurs after treatment. 

New Treatments for Non-Hodgkin’s Lymphoma

There are several treatments for non-Hodgkin’s lymphoma, and scientists are conducting clinical studies to test more treatment approaches. Participation in clinical trials may be recommended for NHL with high-risk features. You can seek the advice of your healthcare provider to find the right one. Some new treatments for non-Hodgkin’s lymphoma include:

  1. Chemotherapy: Recently, several new chemotherapy drugs, like bendamustine and pralatrexate, have been approved for use against certain types of non-Hodgkin’s lymphoma.  
  2. Targeted Therapies: Unlike standard chemotherapy drugs, researchers have developed newer drugs targeting rapidly growing cells. Newer targeted drugs that have shown positive results in early studies include venetoclax, ruxolitinib, crizotinib, duvelisib, etc.
  3. Immunotherapy: While immunotherapies like monoclonal antibodies and immune checkpoint inhibitors are already being used for non-Hodgkin’s lymphoma treatment, new therapies like CAR T-cell therapy have also shown positive results. 
    1. In this treatment, T-cells (a type of immune system cell) are removed from your blood and changed in the laboratory to add specific receptors on their surface. 
    2. The T-cells are multiplied in the lab and injected into the blood to help them attack the lymphoma cells. 
  4. Lymphoma Vaccines: Unlike vaccines for infections, lymphoma vaccines are used to cure rather than prevent the disease. 
    1. These vaccines are immunotherapy designed to stimulate the body’s immune system to recognise and attack lymphoma cells. 
    2. Lymphoma vaccines are still under development and investigation in clinical trials. While they hold promise as a potential treatment approach, they are not yet widely available as standard therapies.

Survival Rates of Hodgkin’s and Non-Hodgkin’s Lymphoma

A relative survival rate compares patients with the same type and stage of disease with the overall population. It identifies the percentage of people with cancer likely to live for a certain time (usually five years) after their diagnosis. However, survival rates are estimates and cannot predict an individual case. They are useful in providing a better understanding of the likelihood of successful treatment. 

Hodgkin’s Lymphoma

The overall five-year survival rate of Hodgkin’s lymphoma is 89%. Survival rates as per different stages are as follows: 

Stage 5-Year Survival Rate
Localised 93%
Regional 95%
Distant 83%

The prognosis for Hodgkin’s lymphoma is generally poorer when the patient:

  1. Has bulky disease or B symptoms
  2. Is male
  3. Is older than 45
  4. Has a high white blood cell count (above 15,000)
  5. Has a low red blood cell count (haemoglobin below 10.5)
  6. Has a low albumin level, a protein made by the liver (below 4)
  7. Has a low lymphocyte count, a type of white blood cell in the immune system (below 600)
  8. Has a high ESR rate (over 30 with B symptoms and over 50 without B symptoms)

Non-Hodgkin’s Lymphoma 

The overall five-year survival rate for individuals with NHL is 74%. However, the survival rates can vary depending on the stages and different types of lymphoma. Patients with non-Hodgkin’s lymphoma usually have a good prognosis when they:

  1. Are 60 or below
  2. In Stage I or Stage II of cancer
  3. Have no lymphoma outside of lymph nodes, or it has spread only to one area outside the lymph nodes
  4. Can function normally and complete daily activities
  5. Have normal serum LDH (elevated LDH levels in the blood indicate tissue damage)

Lifestyle Changes After Lymphoma Treatment

After lymphoma treatment, lifestyle changes can contribute to overall well-being and aid in recovery. The following are the lifestyle changes that can make you feel better and improve your long-term health:

  1. Seek Emotional Support: Prioritise your emotional well-being by seeking support from loved ones, joining support groups, or seeking professional counselling or therapy. Caring for your mental health is crucial.
  2. Manage Stress: Practice stress management techniques like guided imagery, mindfulness, meditation, yoga, or deep breathing exercises. Reserve 20 minutes or more for these exercises every day to gain benefits.
  3. Get a Good Night’s Sleep: Aim for 7-8 hours every night. Getting enough sleep helps improve your health, mood, attention, memory, coping ability, etc. Moreover, avoid screen time and stimulants before bed. It would help to keep your room as dark as possible. 
  4. Regular Exercise: Engage in regular physical activity, as your healthcare team recommends. Exercise can help improve energy levels, increase strength, and manage weight. Avoid sitting or lying down for prolonged periods.
  5. Eat a Nutritious Diet: Focus on a balanced diet rich in fruits, vegetables, and fibre, like whole grains and beans. Stay hydrated and limit processed meats, red meat, high-calorie, low-nutrient food, and excessive alcohol consumption.
  6. Avoid Environmental Toxins: Environmental toxins, like tobacco smoke, can increase your cancer risk. So if you smoke, quit smoking.

Side Effects of Lymphoma Treatment

Treatment for Hodgkin’s and non-Hodgkin’s lymphoma helps destroy lymphoma cells. However, it can also damage several healthy cells, leading to side effects. Side effects may differ from one individual to another and vary depending on the type and duration of treatment. Some common side effects of lymphoma treatment that can affect your day-to-day life include:

  1. Hair loss
  2. Dry, sore, and itchy skin
  3. Fatigue
  4. Bowel problems
  5. Nausea and vomiting
  6. Neuropathy (nerve damage)
  7. Sore mouth
  8. Sleep problems

Other serious side effects of the treatment may include:

  1. Infection
  2. Anaemia (low red blood cells)
  3. Neutropenia (low white blood cells)
  4. Thrombocytopenia (low platelets)
  5. Reduced fertility 
  6. Secondary cancers
  7. Cardiovascular problems
  8. Lung problems

Can Lymphoma Recur?

Yes, lymphoma can recur, meaning it can come back after a period of remission or successful treatment. The risk of recurrence can vary depending on several factors, including the specific type and stage of lymphoma, the initial treatment received, and individual characteristics. 

  1. When lymphoma returns after at least six months of successful treatments, it is said to be relapsed. 
  2. When it returns within six months of treatments, the lymphoma is refractory. 

Classical Hodgkin lymphoma treatment is generally more successful and less likely to relapse. Types of lymphomas more likely to relapse include low-grade non-Hodgkin lymphoma and some high-grade non-Hodgkin lymphomas. 

If lymphoma does recur, further treatment options will be explored based on various factors, like the type and location of the recurrence, the individual’s overall health, and previous treatments. In some cases, additional chemotherapy, radiation therapy, targeted therapy, immunotherapy, or stem cell transplantation may be considered.

When to Consult a Doctor?

If you are undergoing treatment for lymphoma, you should call your doctor when you notice changes in your body that indicate a worsening condition despite the ongoing treatment. If your treatment is complete, you will have regular follow-up appointments so the doctor can monitor your health and look for recurrence signs. 

Call a doctor immediately if you experience persistent side effects that do not subside with prescribed medications or when you experience signs of recurrence, including:

  1. Swollen lymph nodes for more than a few weeks
  2. Night sweats for more than a few weeks 
  3. Unexplained weight loss
  4. Fatigue
  5. Itching
  6. Persistent pain
  7. Changes in bowel movement


The non-Hodgkin and Hodgkin lymphoma treatment has significantly advanced, offering improved patient outcomes and increased hope. Classic Hodgkin lymphoma treatment often combines chemotherapy, radiation therapy, and stem cell transplant. Non-Hodgkin lymphoma treatment approaches vary based on the subtype and stage, including chemotherapy, immunotherapy, radiation therapy, targeted therapy, and stem cell transplantation.

HexaHealth, a leading healthcare provider, can play a vital role in supporting patients with Hodgkin’s and non-Hodgkin’s lymphoma. Our comprehensive and patient-centred approach offers expert medical guidance and healthcare services to help you throughout your treatment journey. Our team of specialists collaborates to create personalised treatment plans, provide emotional support, and ensure the best possible care and outcomes for lymphoma patients. So what are you waiting for? Get in touch with us TODAY!

Suggested Reads, 

Leukemia vs Lymphoma Bone Marrow Cancer Symptoms
Types Of Lymphoma Radiation Therapy for Prostate Cancer

Frequently Asked Questions

What are the Hodgkin lymphoma treatment options?

The specific treatment approach depends on the cancer’s stage, type and characteristics. Hodgkin lymphoma treatment options typically include chemotherapy, radiation therapy, immunotherapy, and stem cell transplantation. Chemotherapy regimens, such as ABVD or BEACOPP, are often combined with radiation therapy. The doctor may also recommend a stem cell transplant when other treatments do not work.

What are the non-Hodgkin’s lymphoma treatment options?

Non-Hodgkin’s lymphoma treatment options include chemotherapy, radiation therapy, stem cell transplant, targeted therapy, and immunotherapy.
Treatment choice depends on the subtype, stage, and individual patient factors. Immunotherapy drugs, such as CAR-T cell therapy, may be employed in certain cases, and radiation therapy or stem cell transplant may be considered for specific situations.

How is Hodgkin’s lymphoma typically treated?

Hodgkin’s lymphoma is typically treated with chemotherapy, radiation therapy, targeted therapy, and, in some cases, stem cell transplantation. The specific treatment approach depends on the stage, subtype, and individual patient factors.

Is classical Hodgkin lymphoma treatable?

Yes, classical Hodgkin lymphoma is generally treatable. It has a high cure rate, especially in the early stages. With advancements in treatment options, such as chemotherapy, radiation therapy, stem cell transplant, and targeted therapy, the prognosis for classical Hodgkin lymphoma treatment has significantly improved, providing hope for patients.

What are stage 1 Hodgkin’s lymphoma treatment options?

Stage 1 Hodgkin’s lymphoma is limited to a single lymph node region or organ. Stage 1 Hodgkin’s lymphoma treatment involves a combination of chemotherapy, such as ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine), and radiation therapy targeted at the affected lymph node or organ. The treatment plan may vary based on individual patient factors and the doctor’s preferences.

What are the treatment approaches for non-Hodgkin’s lymphoma?

Non-Hodgkin’s lymphoma treatment approaches differ on the subtype, stage, and unique individual factors. A multidisciplinary team decides the specific treatment strategy. Common treatment options for this type of lymphoma include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and stem cell transplantation.

Are there differences in treatment between Hodgkin’s and non-Hodgkin’s lymphoma?

While the treatments are usually the same, the approach may differ based on the stage of the disease. Hodgkin’s lymphoma usually involves combined chemotherapy and radiation therapy. In contrast, the treatment for non-Hodgkin’s lymphoma depends on its subtype and may include options like chemotherapy, radiation therapy, immunotherapy, targeted therapy, and stem cell transplant.

What is the standard treatment protocol for Hodgkin’s lymphoma?

The standard Hodgkin lymphoma treatment protocol involves a combination of chemotherapy and radiation therapy. The chemotherapy regimen often used for Hodgkin’s lymphoma includes ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine). The treatment may vary depending on the cancer’s stage and subtype.

Are there targeted therapies available for treating Hodgkin’s and non-Hodgkin’s lymphoma?

Yes, targeted therapies can treat both Hodgkin and non-Hodgkin lymphoma. In Hodgkin’s lymphoma, immune checkpoint inhibitors like pembrolizumab and rituximab have shown efficacy. Non-Hodgkin’s lymphoma can be treated with targeted therapies specific to certain subtypes, such as rituximab for CD20-positive B-cell lymphomas.

What is chemotherapy’s role in treating Hodgkin’s and non-Hodgkin’s lymphoma?

Chemotherapy has a central role in treating both Hodgkin and non-Hodgkin lymphoma. It is usually used as a primary treatment or may be combined with other therapies. Chemotherapy drugs target and destroy cancer cells throughout the body, helping to achieve remission and preventing lymphoma spread or recurrence.

Is radiation therapy commonly used to treat Hodgkin’s and non-Hodgkin’s lymphoma?

Radiation therapy is commonly used for Hodgkin’s and non-Hodgkin’s lymphoma treatment, particularly in localised or early-stage cancer. The therapy involves using high-energy radiation to target and kill cancer cells. It may be used alone or with other treatments like chemotherapy to improve results.

Are there immunotherapy options for Hodgkin’s and non-Hodgkin’s lymphoma treatment?

Immunotherapy options are available for non-Hodgkin and Hodgkin lymphoma treatment. Immunotherapies like rituximab, a monoclonal antibody targeting CD20, are commonly used in non-Hodgkin’s lymphoma treatment. Immune checkpoint inhibitors, like pembrolizumab and nivolumab, have been approved for certain cases of Hodgkin’s lymphoma.

What are the potential side effects of the treatments for Hodgkin’s and non-Hodgkin’s lymphoma?

The potential side effects of non-Hodgkin and Hodgkin lymphoma treatment differ depending on the treatment approach. Common side effects may include hair loss, nausea, fatigue, sore mouth, itchy skin, increased infection risk, lower blood cell count, and long-term complications like secondary cancers and fertility issues.

Can you explain the role of stem cell transplantation in treating Hodgkin’s and non-Hodgkin’s lymphoma?

The role of stem cell or bone marrow transplant in treating Hodgkin’s and non-Hodgkin’s lymphoma is to replenish the blood stem cells in the bone marrow. This helps them to produce healthy new blood cells.

What are the new advancements in Hodgkin lymphoma treatment?

The new advancements in early-stage Hodgkin lymphoma treatment are combination chemotherapy and involved-field radiation therapy (IFRT). Combination chemotherapy may also be used alone. Commonly used first-line chemotherapy regimens for classical Hodgkin lymphoma treatment include a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD).

What are the new advancements in Non-Hodgkin lymphoma treatment?

New treatments for non-Hodgkin’s lymphoma include CAR T-cell therapy. This immunotherapy involves changing a patient’s healthy T-cells so the immune system can recognise and eliminate lymphoma cells. Other advancements may include targeted therapies, different combinations of chemotherapies, genetic testing, etc. 

How is the choice of treatment determined for Hodgkin’s and non-Hodgkin’s lymphoma?

Several treatment options are available for Hodgkin’s and non-Hodgkin’s lymphoma. The choice of treatment is determined based on the characteristics of the lymphoma, like the types of cells involved, the speed of growth, and whether the lymphoma is aggressive. The doctor will also consider your age, overall health, and preferences.

What is the long-term outlook after treatment for Hodgkin’s and non-Hodgkin’s lymphoma?

The long-term outlook after treatment for Hodgkin’s and non-Hodgkin’s lymphoma may depend on a patient’s situation. However, Hodgkin lymphoma's five-year relative survival rate is generally higher than non-Hodgkin lymphoma. While the survival rate may vary depending on the lymphoma subtype, the overall five-year relative survival rate for non-Hodgkin and Hodgkin lymphoma is 74% and 89%, respectively.

What supportive care options are available during and after treatment for Hodgkin’s and non-Hodgkin’s lymphoma?

Supportive care options during and after treatment for Hodgkin’s and non-Hodgkin’s lymphoma may include treatment to manage the various physical, social, emotional, and financial side effects. It aims to improve your quality of life, maintain independence by decreasing symptoms, manage pain, and support you and your family.

What is the role of surgery in treating Hodgkin’s and non-Hodgkin’s lymphoma?

Surgery is often used to get a biopsy sample to diagnose and classify the lymphoma, but it is rarely used as a form of treatment for Hodgkin’s and non-Hodgkin’s lymphoma. This is because chemotherapy, radiotherapy, and targeted therapy usually work well and are the primary options.

Surgery may be needed to remove limited disease from the affected organ like the stomach or small bowel, or spleen in splenic marginal zone lymphoma (a rare type of lymphoma).

How do the stage and subtype of lymphoma influence the treatment options for Hodgkin’s and non-Hodgkin’s lymphoma?

The stage and subtype of Hodgkin’s and non-Hodgkin’s lymphoma help determine cancer's spread and severity and treatment's effect. They help decide whether to use chemotherapy, radiation therapy, immunotherapy, targeted therapy, stem cell transplantation, or a combination of two or more treatments.


All the articles on HexaHealth are supported by verified medically-recognized sources such as; peer-reviewed academic research papers, research institutions, and medical journals. Our medical reviewers also check references of the articles to prioritize accuracy and relevance. Refer to our detailed editorial policy for more information.

  1. Hodgkin Lymphoma Treatment Protocol by Stage [Internet]. www.cancer.org. [cited 2023 Jun 5].link
  2. Hodgkin Lymphoma Stages | Hodgkin Disease Stages [Internet]. www.cancer.org. link
  3. What’s New in Non-Hodgkin Lymphoma Research and Treatment? [Internet]. www.cancer.org.link
  4. Lymphoma Action | Side effects of lymphoma treatment [Internet]. Lymphoma Action.link
  5. Hodgkin Lymphoma Survival Rates | Hodgkin Disease Survival Rates [Internet]. www.cancer.org.link
  6. Hodgkin Lymphoma Survival Rates | Hodgkin Disease Survival Rates [Internet]. www.cancer.org.link
  7. Watson S. Treatments for B-Cell Lymphoma [Internet]. WebMD.link
  8. 6 Lifestyle Changes to Improve Your Cancer Care [Internet]. Cancer.net. 2018.link

Updated on : 5 June 2023


About Authors

HexaHealth Care Team

HexaHealth Care Team brings you medical content covering many important conditions, procedures falling under different medical specialities. The content published is thoroughly reviewed by our panel of qualified doctors for its accuracy and relevance.

Related Expert Doctors

Dr. Akshay Tiwari

Dr Akshay Tiwari

Cancer Care / Oncology

16 Years Experience

like100 % Recommended
Dr. Stuti Gupta

Dr Stuti Gupta

Surgical Oncology

10 Years Experience

like97 % Recommended
Dr. Tapan Singh Chauhan

Dr Tapan Singh Chauhan

Surgical Oncology

14 Years Experience

like97 % Recommended

Related Hospitals

BH Salvas Hospital

BH Salvas Hospital 

Chandan Palace

rating4.89/5 Rating
CDAS Super Speciality Hospital

CDAS Super Speciality Hospital 

Malibu Town

rating4.55/5 Rating
Diyos Hospital, Safdarjung Enclave
get the app
get the app

Download HexaHealth App

Get free consultation with our expert doctors, store all your health records at one place and get real time updates of appointments, consultations & surgery.